2224 Organometallics, Vol. 15, No. 9, 1996
Koide et al.
[(tBu)Al(µ3-O)]9 . [(tBu)7Al5(µ3-O)3(µ-OH)2]. This ob-
served cocatalytic activity correlates with the predicted
latent Lewis acidity of the alumoxanes, providing
further evidence for the intimate association of the
alumoxane and the palladium site during catalysis. The
steric effects of the catalyst active site, as determined
by the alkyl bridge length (n) in R2P(CH2)nPR2 and the
alkyl substituents R, were probed for the catalyst
precursor compounds [R2P(CH2)nPR2]Pd[C(O)tBu]Cl.
The concept of pocket angle (or interior cone angles) has
been developed as an aid to understanding the steric
effects of chelating phosphines.
This study has allowed for an understanding of the
identity of the active site in the palladium-alumoxane-
catalyzed copolymerization of ethylene and carbon
monoxide. Our results indicate that consideration of the
transition-metal center is not enough. The alumoxane’s
structure and ability to accept anionic ligands affect
activity. The alumoxane thus has a moderating effect
on the active site, possibly by complexation to the
palladium. A similar effect has been observed for the
zirconocene-alumoxane-catalyzed polymerization of eth-
ylene.12
compounds to study bioinorganic systems.52 Our future
studies will be aimed at further understanding this
enzyme-like picture of inorganic transition-metal-alu-
moxane catalyst systems.
Exp er im en ta l Section
Copolymerizations were carried out in an autoclave (Berg-
hof, Germany) equipped with a Teflon liner (105 mL). Mass
spectra were obtained on a J EOL AX-505 H mass spectrometer
operating with an electron beam energy of 70 eV for EI mass
spectra. Ammonia was used as the reagent gas for CI
experiments unless otherwise mentioned. Infrared spectra
(4000-400 cm-1) were obtained using Nicolet 5ZDX-FTIR and
Perkin-Elmer 1600 series spectrometers; samples were pre-
pared as CH2Cl2 solutions or Nujol mulls. NMR spectra were
obtained on Bruker AM-500, Bruker AM-400, and Bruker AM-
300 spectrometers using (unless otherwise noted) dichlo-
romethane-d2.
All synthetic procedures were performed under purified
nitrogen using standard Schlenk techniques or in an argon
atmosphere VAC glovebox unless otherwise mentioned. Sol-
vents were distilled and degassed prior to use. [(tBu)7Al5(µ3-
O)3(µ-OH)2], [(tBu)Al(µ3-O)]6, [(tBu)Al(µ3-O)]7, and [(tBu)Al(µ3-
O)]9 were prepared as previously reported.14,15 Carbon
monoxide, ethylene, and carbon monoxide/ethylene mixture
(48.7% CO) gases were obtained from Matheson Gas. (dppp)-
Henderson49 has recently suggested that many met-
alloenzymatic reactions may be conceptualized from
prior knowledge in organometallic chemistry. In con-
trast, we believe that the cocatalytic function of the
alumoxane, and the description of the phosphine “pocket”
around the palladium center on which polymerization
occurs, requires a view of transition-metal-alumoxane
catalyst systems that is closer to that of a metalloen-
zyme than to traditional transition-metal catalyst sys-
tems.
t
Pd(OAc)2, dppe, dppb, dmpe, dcpe, Pd(PPh3)4 (Strem), BuC-
t
(O)Cl, EtC(O)Cl, PhC(O)Cl, and BuMgCl (Aldrich) were used
as received. Bis(diphenylphosphino)propane (dppp) was re-
crystallized from CH2Cl2.
(P h 3P )2P d [C(O)tBu ]Cl. To a solution of Pd(PPh3)4 (1.55
t
g, 1.34 mmol) in toluene (80 mL) was added BuC(O)Cl (0.16
mL, 1.40 mmol). The resulting solution was stirred at ambient
temperature for 1 h under a dimmed light. Adding Et2O (80
mL) and cooling to -20 °C yielded a light yellow precipitate,
which was filtered and dried under vacuum. Yield: 0.66 g,
66%. 1H NMR: δ 7.75 (12H, s, o-CH), 7.39-7.44 (18H, m,
m-,p-CH), 0.57 [9H, s, C(CH3)3].
(d p p p )P d [C(O)tBu ]Cl. (Ph3P)2Pd[C(O)tBu]Cl (0.66 g, 0.88
mmol) was suspended in toluene (50 mL), and dppp (0.36 g,
0.88 mmol) was added. The solution was stirred overnight.
Addition of Et2O (50 mL) gave a pale yellow precipitate, which
was recrystallized from CH2Cl2. Yield: 0.31 g, 55%. 1H
NMR: δ 7.9-7.5 (8H, br, o-CH), 7.38 (8H, br, m-CH), 7.29 (4H,
br, p-CH), 2.58 [2H, q, J (H-H) ) 5.0 Hz, P-CH2CH2], 2.08
and 2.39 (4H, m, P-CH2), 0.83 [9H, s, C(CH3)3].
The Lewis acidic abstraction of an anionic ligand from
a transition metal (cf. eq 4) is well understood, and we
have shown that the ability of any alumoxane to do so
is related to its latent Lewis acidity (cf. eq 10). In
contrast to previous proposals,40-43 we propose that
instead of acting as a simple noncoordinating anion, the
alumoxane is complexed to the “cationic” palladium
center during some or all of the steps in the catalytic
cycle. Thus, the alumoxane may be thought of as having
a stabilizing/cooperating effect on the “cationic” pal-
ladium center, in a similar manner to the histidine
ligands present in hemoglobin and cytochrome C oxi-
dase.50,51 The diagrammatic representation of the pal-
ladium-alumoxane complex shown in XVII may be
thought of as a model for a catalyst resting state, with
the active state involving dissociation (either partial or
complete to form an ion pair) of the alumoxane anion.
It is particularly attractive to think of the alumoxane
stabilizing the palladium catalyst at the points around
the catalytic cycle shown in Scheme 2, where the
palladium is shown as being formally three-coordinate.
The effective binding of the alumoxane as well as its
ability to abstract the ancillary ligand (OAc- or Cl-)
thus has a major control over the activity of the catalyst
system. The size (and possibly shape) of the phosphine’s
pocket appears to have an effect analogous to that of
the amino acid residues in the peptide chain surround-
ing a metal center in a metalloenzyme. The reverse
analogy is commonly used to justify the use of model
(d p p e)P d [C(O)tBu ]Cl. This compound was prepared us-
ing a procedure analogous to that described for (dppp)Pd-
[C(O)tBu]Cl. Yield: 40%. 1H NMR: δ 7.84 (12H, m, o-CH),
7.74 (6H, m, p-CH), 7.53 (12H, m, m-CH), 2.50 (2H, br,
P-CH2), 0.88 [9H, s, C(CH3)3].
(d p p b)P d [C(O)tBu ]Cl. This compound was prepared us-
ing a procedure analogous to that described for (dppp)Pd-
[C(O)tBu]Cl. Yield: 31%. 1H NMR: δ 7.67 (12H, m, o-CH),
7.34 (6H, m, p-CH), 7.28 (12H, m, m-CH), 2.4-1.8 (8H, m,
CH2), 0.80 [9H, s, C(CH3)3].
(d m p e)P d [C(O)tBu ]Cl. (Ph3P)2Pd[C(O)tBu]Cl (1; 0.08 g,
0.11 mmol) was suspended in toluene (70 mL), and dmpe (17.8
µL, 0.11 mmol) was added. The solution was stirred for 3 h,
and then Et2O (50 mL) was added to yield a pale yellow
precipitate. The precipitate was collected by filtration and
(52) See for example: (a) Tang, S. C.; Koch, S.; Papaefthymiou, G.
C.; Foner, S.; Frankel, R. B.; Ibers, J . A.; Holm, R. H. J . Am. Chem.
Soc. 1976, 98, 2414. (b) Lane, R. W.; Ibers, J . A.; Frankel, R. B.;
Papaefthymiou, G. C.; Holm, R. H. J . Am. Chem. Soc. 1977, 99, 84. (c)
Collman, J . P. Acc. Chem. Res. 1977, 10, 265. (d) Groves, J . T. Adv.
Inorg. Biochem. 1979, 1, 119. (e) Armstrong, W. H.; Spool, A.;
Papaefthymiou, G. C.; Frankel, R. B.; Lippard, S. J . J . Am. Chem. Soc.
1984, 106, 3653. (f) Spool, A.; Williams, I. D.; Lippard, S. J . Inorg.
Chem. 1985, 24, 2156. (g) Caradonna, J . P.; Reddy, P. R.; Holm, R. H.
J . Am. Chem. Soc. 1988, 110, 2139. (h) Craig, J . A.; Holm, R. H. J .
Am. Chem. Soc. 1989, 111, 2111.
(49) Henderson, R. A. J . Chem. Soc., Dalton Trans. 1995, 177.
(50) Dickerson, R. E.; Geis, I. Hemoglobin; Benjamin/Cummings:
Menlo Park, CA, 1983.
(51) Meyer, T. E.; Kamen, M. D. Adv. Protein Chem. 1982, 35, 105.